Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
36,545
Total Claims
$9.6M
Drug Cost
1,402
Beneficiaries
$6,859
Cost/Patient
Risk Score Breakdown 16/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
+350%
Cost per patient vs peers
$6,859 vs $1,524 avg
+83%
Brand preference vs peers
25.0% vs 13.7% avg
Opioid Prescribing
0.1%
Opioid Rate
30
Opioid Claims
$519
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 9,125 claims · $8.2M
Generic: 27,383 claims · $1.4M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 1,299 | $1.2M |
| Apixaban | 835 | $743K |
| Icosapent Ethyl | 919 | $527K |
| Empagliflozin | 560 | $517K |
| Lipase/Protease/Amylase | 222 | $403K |
| Sacubitril/Valsartan | 375 | $399K |
| Rivaroxaban | 453 | $390K |
| Macitentan | 27 | $346K |
| Semaglutide | 206 | $324K |
| Finerenone | 294 | $312K |
| Ranolazine | 1,570 | $289K |
| Bempedoic Acid/Ezetimibe | 312 | $231K |
| Linaclotide | 277 | $227K |
| Ticagrelor | 319 | $217K |
| Riociguat | 20 | $215K |
Prescribing Profile
Patient Profile
78
Avg Age
54%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data